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Background: Emergency departments may be a useful information source to describe the demographics and
clinical characteristics of patients with acute cocaine-related medical problems. We therefore conducted a
retrospective analysis of 165 acute, laboratory-confirmed cocaine intoxications admitted to an urban emergency
department in Switzerland between January 2007 and March 2011.
Results: A total of 165 patients with a mean age of 32 years were included. Most patients were male (73%) and
unemployed (65%). Only a minority (16%) had abused cocaine alone while 84% of the patients had used at least
one additional substance, most commonly ethanol (41%), opioids (38%), or cannabis (36%) as confirmed by their
detection in blood samples. The most frequently reported symptoms were chest pain (21%), palpitations (19%),
anxiety (36%) and restlessness (36%). Psychiatric symptoms were present in 64%. Hypertension and tachycardia
were observed in 53% and 44% of the patients, respectively. Severe poisonings only occurred in patients with
multiple substance intoxication (15%). Severe intoxications were non-significantly more frequent with injected drug
use compared to nasal, oral, or inhalational drug use. Severe complications included acute myocardial infarction
(2 cases), stroke (one case), and seizures (3 cases). Most patients (75%) were discharged home within 24 h after
admission. A psychiatric evaluation in the ED was performed in 24% of the patients and 19% were referred to a
psychiatric clinic.
Conclusions: Patients with acute cocaine intoxication often used cocaine together with ethanol and opioids and
presented with sympathomimetic toxicity and/or psychiatric disorders. Severe acute toxicity was more frequent
with multiple substance use. Toxicity was typically short-lasting but psychiatric evaluation and referral was often
needed.
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After cannabis, cocaine is the most-used illicit drug in
Europe [1-3]. In Europe, 4.3% of adults aged 15–64 have
used cocaine at least once in their lifetime [4]. In Spain, as
many as 5.9% of people aged 15–64 years reportedly used
cocaine at least once during their lifetime [2]. Use of co-
caine among Swiss adolescents has increased from 3.8% in
1993 to 9.8% in 2002 [5] and the lifetime prevalence of* Correspondence: Matthias.liechti@usb.ch
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1.7% in 2002 to 2.8% in 2007 [6].
Cocaine is one of the leading drugs of abuse resulting
in presentations to emergency departments (EDs) in the
Western world. Cocaine-related ED visits have increased
by 47% in the US from 1995 to 2002 [7]. Cocaine was
second only to ethanol as the cause of acute intoxication
in patients who presented to a Spanish ED [2].
Cocaine is a central nervous system stimulant which
produces euphoria, restlessness, and reduced appetite
[8-10]. It is commonly abused by inhalation, nasal insuf-
flation or intravenous injection. Cocaine can affect all
body systems potentially resulting in many adverse ef-
fects. Among the most severe complications are seizures,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(MI), aortic dissection, rhabdomyolysis, mesenteric is-
chemia, acute renal injury, and multiple organ failure
[11]. Results from two retrospective ED studies in the
US suggested that cocaine-related problems are short-
lived in most cases and primarily include cardiovascular
(chest pain, palpitations) and neuropsychiatric (dizziness,
headache, restlessness, anxiety, psychosis) symptoms
[12,13]. Cocaine increases myocardial oxygen consump-
tion and induces coronary artery vasoconstriction [14],
facilitates platelet aggregation, and thrombus formation
[15-18]. Furthermore, cocaine predisposes to ventricular
arrhythmia [19]. Accordingly, acute myocardial infarc-
tion (MI) is the most frequent severe cardiovascular
complication in cocaine abusers. Three large studies
showed that 4-6% of patients who present with cocaine-
related chest pain sustain acute MI [20-22]. Ischemic or
hemorrhagic stroke, sudden death or seizures related to
cocaine use have also been infrequently reported [8,12].
Information regarding cocaine- and other illicit drug-
related health problems is scarce in Europe. EDs may
be important sources of information about drug-related
health consequences [1,23]. Reports from 30 European
countries regarding cocaine-related health emergency epi-
sodes have recently been summarized for the period from
2007 to 2010 [1]. However, most of these reports con-
cerned calls to poison centers, or admissions to general
hospitals, psychiatric hospitals or toxicology clinics. Only
7 reports used EDs as information sources and detailed
case descriptions were not presented [1]. The present
study aimed to describe in more detail the demographics,
clinical findings, management, and short-term outcome of
patients with analytically-confirmed acute cocaine use pre-
senting to an urban ED in Switzerland.
Methods
This observational study was approved by the ethics com-
mittee of the cantons of Basel. We retrospectively identi-
fied and included all patients admitted to the ED of the
University Hospital of Basel with acute cocaine-related
medical problems between January 2007 and March 2011.
The ED is both a primary care facility (walk-in patients)
and a tertiary referral center for hospitals in the greater
Basel area. Additionally, all patients brought by the para-
medics are first admitted to the ED. All ED presentations
are entered into the comprehensive electronic patient
chart data-base. We performed full-text search to identify
all cases with notions of “cocaine”, or related terms (“free-
base” or “crack”) in their electronic chart. The search was
performed in the entire text entered by the admitting
physician. The entire charts of all cases were then
reviewed including all the data obtained by paramedics.
Only cases with acute cocaine intoxication were included
in the study. A case with acute cocaine-related medicalproblems (acute cocaine intoxication) was defined as a pa-
tient with any medical problem related to self-reported co-
caine use within the last 12 h and confirmation of the
presence of cocaine in blood serum by the CEDIA cocaine
immunoassay (Thermo Fisher Scientific, Bonn, Germany).
Patients who did not admit to the use of cocaine were also
included in the study if they presented with typical symp-
toms and signs of sympathetic stimulation and a positive
laboratory test for cocaine. Patients with self-reported co-
caine use more than 12 h before presentation or patients
with a negative blood test as well as body packers and
body stuffers were excluded from the study. Analytical
confirmation of the use of other drugs of abuse including
cannabis, amphetamines including MDMA, benzodiaze-
pines, methadone, opioids, and LSD was also performed
using CEDIA immunochemical assays in blood serum.
Ethanol blood levels were determined by an enzyme assay.
Blood levels of γ-hydroxybutyrate (GHB) levels were de-
termined by high-pressure liquid chromatography only in
patients with suspected GHB intoxication. All laboratory
analyses were performed in the hospital clinical chemistry
department according to good laboratory practice. Data
abstracting was performed in a standardized manner by
one of the authors for the entire study. Demographic data
included age, sex, hour and weekday of ED admission, and
employment status. The medical history included the rea-
son for admission, present symptoms, history of drug use,
route of drug administration, and context of use. We also
recorded any co-ingestion of ethanol or other drugs as re-
ported by the patient and as confirmed in the toxicological
blood analyses described above. Clinical variables included
the Glasgow Coma Scale (GCS) score, heart rate, blood
pressure, respiratory rate, body temperature, oxygen satur-
ation, and laboratory tests. Patients were divided into two
groups: patients who used only cocaine and patients who
used cocaine together with other drugs based on the blood
tests. Severity of poisoning was assessed using the Poison
Severity Score for grading acute poisoning [24]. Mild tox-
icity refers to mild, transient and spontaneously resolving
symptoms, moderate toxicity refers to pronounced or pro-
longed symptoms, and severe toxicity indicates severe or
life-threatening symptoms. Differences in the frequency of
clinical characteristic between the cocaine monointoxi-
cated and the polyintoxicated patients (according to la-
boratory findings) were assessed using Fisher’s exact tests.
We and others have previously used similar methods to
characterize acute intoxications with GHB [25,26], ecstasy
[27], and methylphenidate [28].
Results
The electronic search in the hospital data-base in a total
of 172,207 ED patients during the study period identified
930 patients with notions of cocaine or related terms in
the electronic record. Of these patients, 174 presented
Table 1 Patient characteristics
Number of cases, N = 165 (%)
Gender
Male 121 (73)
Female 44 (27)
Age/years
16-20 15 (9)
21-30 70 (42)
31-40 54 (33)
>40 26 (16)
Time of presentation
Night arrival (20:00 – 8:00 h) 106 (64)
Weekend arrival (Friday 17:00
h – Monday 8:00 h)
70 (42)
Context of drug use
Recreational abuse 150 (91)
Suicide attempt 7 (4)
Unintentional/criminal 6 (4)
Not reported 2 (1)
Route of cocaine administration
Intravenous 46 (28)
Nasal 46 (28)
Inhalational 4 (2)
Oral 6 (4)
Not reported 63 (38)
Concomitant drug use Self-reported Laboratory-
confirmed
None 32(19) 27 (16)
Ethanol 76 (46) 68 (41)
Opioids 43 (26) 63 (38)
Cannabis 29 (18) 59 (36)
Benzodiazepines 18 (11) 28 (17)
Amphetamines (including ecstasy) 6 (4) 2 (1)
GHB, GBL 4 (2) 1 (1)
LSD 1 (1) 0 (0)
History of chronic cocaine use
Yes 102 (62)
No 29 (18)
Not reported 34 (21)
Employment
Yes 29 (18)
No 107 (65)
Not reported 29 (18)
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verified by the full chart review. Of these 174 patients, 9
subjects were excluded because blood serum tests were
negative for cocaine. Of the total 165 cases included in
the present study, 151 (92%) reported cocaine abuse
within 12 hours prior to presentation. Fourteen (8%) pa-
tients without self-reported cocaine use but with a po-
sitive blood serum test for cocaine and sympathetic
toxicity were judged as being acutely intoxicated with
cocaine. The demographic data are presented in Table 1.
The annual number of presentations due to cocaine-
related acute medical problems per total patients seen in
the ED was 27/36,660 cases in 2007, 48/40,021 cases in
2008, 39/41,744 cases in 2009, 44/43,025 cases in 2010,
and 7/10,757 cases from January to March 2011. The
mean patient age ± SD was 32 ± 9 years and most were
male and unemployed. Most patients were admitted to
the ED at night and 98 (59%) patients were brought to
the ED by ambulance. Intravenous or nasal administra-
tions of cocaine were most common and equally fre-
quent. Most patients used other drugs together with
cocaine (Table 1). According to the blood serum tests,
25 (15%) patients abused cocaine alone whereas in 140
(85%) patients at least one additional substance was
identified in the blood. Ethanol, opioids, cannabis, and
benzodiazepines were the most commonly detected
drugs while amphetamines were infrequently found
(Table 1).
The clinical patient characteristics are summarized in
Table 2. Among all 165 cases, 21 (13%) presented with se-
vere intoxication but there were no fatalities. Severe intoxi-
cation was more frequent among polyintoxicated patients
compared to intoxication with cocaine alone (Table 2). All
21 cases of severe toxicity and all 7 cases with a hospital
stay longer than 24 hours were due to intoxication with
cocaine and at least one other substance. The most com-
monly reported symptoms were chest pain, palpitations,
anxiety, restlessness, somnolence, weakness, nausea/vomit-
ing, and psychotic symptoms. Psychiatric symptoms were
reported in 106 (64%) of the patients (Table 2). Hyperten-
sion and/or tachycardia were present in about half of the
patients (Table 2). Two cases of myocardial infarction (one
with and one without ST elevation) were observed in the
multidrug user group. Both patients were admitted to the
Intensive Care Unit and underwent coronary angiography.
Decreased consciousness (GCS < 13) at any time during
the ER presence was predominantly observed in the multi-
drug user group. Twenty-five (18%) of the 138 patients
with multiple drug use had a GCS score below 13 any time
during presence at the ED. Of these patients, all co-
ingested either ethanol (10 cases) or opioids (11 cases) or
both (4). Only 2 of the 27 patients in the cocaine alone
using group had a GCS score below 13; one of these re-
ported co-use of baclofen and the other co-use of GHB.Three cases of self-limited generalized seizures reportedly
occurred in the total sample of 165 patients. Two of the
three patients used heroin and one ethanol in addition to
cocaine and one had a history of epilepsy. One patient
Bodmer et al. BMC Research Notes 2014, 7:173 Page 4 of 7
http://www.biomedcentral.com/1756-0500/7/173with cocaine and barbiturate use suffered an ischemic
stroke and was admitted to the neurology ward.
Severity of intoxication was not significantly associ-
ated with the route of drug administration. However,Table 2 Clinical characteristics of acute cocaine intoxication
All cases
No. (%)
Total N = 165
Severity of poisoning
Severe poisoning 21 (13)
Cardiovascular
Chest pain 35 (21)
Palpitations 32 (19)
Dyspnea 21 (13)
Hypertension (systolic pressure >140 mmHg) 87 (53)
Tachycardia (>100 beats per minute) 72 (44)
Myocardial infarction 2 (1)
Hyperthermia >38.0°C 15 (9)
Hypoxemia (oxygen saturation <95%) 20 (12)
Psychiatric
Anxiety 60 (36)
Restlessness 60 (36)
Hallucinations, paranoia, or psychosis 23 (14)
Agitation 37 (22)
Depression 32 (19)
Insomnia 18 (11)
Suicide ideation 15 (9)
Disorientation 17 (10)
Neurologic
Impaired consciousness, GCS <9 17 (10)
Impaired consciousness, GCS 9-12 10 (6)
Impaired consciousness, GCS <13 27 (16)
Dizziness 24 (15)
Headache 16 (10)
Paresthesia 15 (9)
Seizure 3 (2)
Tremor 3 (2)
Stroke 1 (1)
Miscellanous
Weakness 50 (30)
Nausea or vomiting 25 (15)
Myocloni or muscle cramps 9 (5)
Muscle pain 12 (7)
Abdominal pain 15 (9)
Elevated creatine kinase (>250 U/L) 73 (44)
*significant group difference (Fisher’s exact test, *p < 0.05).severe intoxications occurred in 7 of 46 patients (15%)
with intravenous drug use (cocaine or other drug) and
in 5 of 57 patients (9%) with nasal, oral or inhalational
drug administration. Hospitalization longer than 24 hUse of cocaine with other drugs Use of cocaine alone
No. (%) No. (%)
Total N = 138 Total N = 27
21 (15) 0 (0)*
32 (23) 3 (11)
23 (17) 9 (33)
16 (12) 5 (19)
70 (51) 17 (63)
62 (45) 10 (37)
2 (1) 0 (0)
12 (9) 3 (11)
18 (13) 2 (7)
46 (33) 14 (52)
47 (34) 13 (48)
14 (10) 9 (33)
28 (20) 9 (33)
28 (20) 4 (15)
18 (13) 0 (0)
12 (9) 3 (11)
15 (11) 2 (7)
15 (11) 2 (7)
10 (7) 0 (0)
25 (18) 2 (7)
21 (15) 3 (11)
14 (10) 2 (7)
11 (8) 4 (15)
2 (1) 1 (4)
3 (2) 0 (0)
1 (1) 0 (0)
49 (36) 1 (4)
21 (15) 4 (15)
7 (5) 2 (7)
10 (7) 2 (7)
13 (9) 2 (7)
62 (45) 11 (41)
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in 4 (7%) of the patients using other routes of cocaine
administration.
Therapeutic measures included the administration of
intravenous fluids in 80 (48%) patients and of benzodiaze-
pines for the treatment of cardiovascular toxicity and psy-
chostimulation in 52 (32%) cases. Naloxone and flumazenil
were administered in 14 (8%) and 2 (1%) patients, respect-
ively. Forty patients (24%) were evaluated by a consultant
psychiatrist on site. One hundred and twenty four (75%)
patients were discharged home and 31 (19%) were referred
to a psychiatric institution. Psychiatric hospitalization was
needed in 7 of the 27 patients who used cocaine alone
(26%) and in 24 of the 138 patients who used cocaine with
other substances (17%). Similarly, psychiatric evaluation by
consulting psychiatrists on the ER occurred nonsignifi-
cantly more frequently among cocaine only intoxications
(9 cases, 33%) compared with polyintoxications (31 cases,
22%) (p = 0.22). Severity of intoxication did not signifi-
cantly influence the frequency of psychiatric evaluations. A
consultant was present in 37 of 107 mild to moderate in-
toxications (26%) and in 3 of 18 severe intoxications (14%).
However, psychiatric hospitalization occurred only in mild
to moderate intoxications (31 patients of 144 or 22%) while
all 21 severe intoxications remained in general medical
care (p < 0.05).
All patients with acute myocardial infarction were ad-
mitted to the ICU where coronary angiography was per-
formed in both and stenting in the one with ST
elevation MI. The one patient with an ischemic stroke
was admitted to the neurology ward. Nineteen (12%) pa-
tients left the ED against medical advice. Among 68 pa-
tients exhibiting minor toxicity only one (1%) stayed for
more than 24 h, among 76 patients with moderate tox-
icity three (4%) stayed for more than 24 h, and among
the 21 patients with severe toxicity three (14%) stayed
for more than 24 h. Of the 21 patients with severe in-
toxication 18 (86%) were discharged within 24 h.
Discussion
In this study we described acute medical problems in pa-
tients with blood-test confirmed cocaine use. Most pa-
tients were men who chronically abused cocaine and had
no employment. Of note, 53% of the patients were over
30 years old in line with increases in age of patients with
cocaine-related health problems in other European coun-
tries [1]. The patients who abused more than one drug did
so most commonly by combining cocaine with ethanol,
opioids or cannabis, as reported by others [12,29]. We
found that such polydrug use lead to significantly more se-
vere intoxications compared with the use of cocaine alone.
Co-use of ethanol was predominant in the present and in
the previously studied series of cocaine intoxications [2].
Ethanol co-use with cocaine forms cocaethylene but alsoincreases the plasma levels of cocaine, cocaine-induced
subjective and also its cardiostimulant effects [30-32].
Ethanol may therefore increase the toxicity of cocaine
[31,33] consistent with our findings. In accordance with
data from the US [12], most visits occurred during night
time. In our study, cocaine was mostly abused nasally or
intravenously while predominantly intravenous and inha-
lational use was reported in the US [12,34] and mainly
nasal administration was documented in Spain [2]. It is
possible that intravenous drug use is overrepresented in
our sample because it may lead to increased utilization of
the ED due to more severe complications. Severe toxicity
was more frequent with injection drug use compared to
other routes of administration but this association was not
statistically significant in the present study. In our study
and in line with the work by others [2,12], co-use of other
stimulants such as amphetamines or methylphenidate was
hardly ever reported and amphetamines were only sporad-
ically detected in the blood. In a recent analysis of expo-
sures reported to the Swiss Toxicological Information
Centre, co-use of amphetamines was noted in about 10%
of the cocaine user [35]. Use of GHB was very rarely re-
ported in our study whereas 15% of GHB users who pre-
sented to an ED in Zurich reported co-ingestion of
cocaine [25]. In Spain, co-use of GHB in patients with co-
caine intoxication was reported in only 6% of patients [2].
Use of methylphenidate was not reported in our study in
accordance with an analysis of a small number of methyl-
phenidate users presenting to the Basel ED [28] who did
not co-use cocaine. In contrast, cocaine users with opioid
substitution therapy in the Basel area indicate that they
misuse methylphenidate orally, nasally, or intravenously as
a substitute for cocaine [36]. Thus, methylphenidate co-
use may have gone undetected because, contrary to other
amphetamines, it was not detected by the blood screening
test. Taken together, the data indicate that cocaine is not
typically combined with other stimulants but rather co-
used with sedating drugs including opioids, ethanol, or
cannabis.
Chief complaints associated with acute cocaine toxicity
were mainly neuropsychiatric or cardiovascular. The
most commonly reported symptoms included anxiety,
restlessness, agitation, chest pain and palpitations similar
to previous studies [12,13]. Sixty-four percent of the pa-
tients presented with psychiatric symptoms similar to
the 55-61% reported by recent previous studies [2,29]
but higher than the 31-37% reported by earlier studies
[12,37]. Loss of consciousness occurred in the multidrug
user group, mainly due to concomitant use of ethanol or
opioids. Hypertension and tachycardia were the main
clinical signs regardless whether cocaine was used alone
or in combination with other substances. Twenty-one
percent of the patients reported chest pain. Percentages
of patients reporting chest pain ranged from 11-39% in
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from cocaine-related acute MI. MI similarly occurred in
1% of the patients presenting with cocaine toxicity and in
6% [12] of those with cocaine-associated chest pain in other
studies [20,21]. Cardiovascular problems including myocar-
dial infarction and arrhythmias are well-known medical
complications of cocaine use [29,38,39]. Cocaine use has
been observed in about 25% of 18–45 year-old patients
with myocardial infarctions in [40]. Myocardial infarction
may result from vasospasms [41] and excessive sympathetic
activation. However, most cardiac deaths occur in patients
with chronic cocaine use [42] and may involve structural
cardiovascular disease including myocardial hypertrophy
and microangiopathy [43-46]. In the presents study, both
cases of cocaine-induced myocardial infarction occurred in
chronic cocaine users. Stenting of significant coronary ar-
tery stenosis was performed in one while no coronary flow
limitation was detected in the other. Similar to acute MI,
cocaine use is an important risk factor for ischemic or
hemorrhagic stroke in younger patients without classical
cardiovascular risk factors [8,47,48]. In the present study,
there was one patient with cocaine-induced ischemic stroke
without other known risk factors except for tobacco smok-
ing. Potential mechanisms of cocaine-induced ischemic
or hemorrhagic stroke include arterial hypertension,
vasospasm, disruption of cerebrovascular autoregula-
tion, and enhanced platelet aggregation [8,41,49]. Other
severe neurological complications in our study included
3 cases of self-limited seizures (2%). In all cases the pa-
tients had used other substances in addition to cocaine
(heroin in 2 cases and ethanol in 1 case). Furthermore,
one patient had a known history of seizures. Self-limited
seizures were reported in 3-4% of patients in previous
studies [12,50].
In our study, the management of patients included ad-
ministration of intravenous fluids and benzodiazepines
to control central and peripheral manifestations of sym-
pathetic toxicity. The majority of patients including most
patients with severe acute intoxications could be dis-
charged home after less than 24 hours of observation in
the ED as shown previously [12,34]. However, a signifi-
cant number of patients needed psychiatric evaluation
and referral.
This study has several limitations. As in all retrospect-
ive studies, there was some missing data and the initial
patient histories and clinical data were not recorded in a
standardized manner. In addition, it is possible that a
few patients with positive drug tests for cocaine and use
before 12 h prior to presentation were misclassified as
acute intoxications. Similarly, acute co-use of cannabis
was likely overestimated based on positive blood tests.
In contrast, there was no screen for GHB in all patients
and co-use of GHB may have gone undetected. As in all
such studies, data from only one large ED may not berepresentative and reflect local drug using trends. Add-
itionally, severe toxicity may have been overrepresented
because we act as referral center for the Basel area in-
cluding parts of France and Germany.
Our study has also several strengths. We had detailed
patient and clinical data documentations in contrast to
studies based on coded diagnoses or analyses of poison
center data. In addition, the exposure to cocaine was
confirmed in the blood for all patients and confirmative
blood tests results for co-used ethanol and illicit drugs
were also available for the majority of patients.
Conclusion
Patients with acute cocaine intoxications presented with
sympathomimetic toxicity or psychiatric disorders. Most
patients co-used other drugs and polydrug use was a risk
factor for more severe toxicity. Most patients could be
discharged within 24 h. However, the proportion of pa-
tients needing further psychiatric evaluation and treat-
ment was remarkable.
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